Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment

Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS

(2013) J. Hobart et al.   NEUROLOGY

4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review

(2013) Henrik Boye Jensen et al.   Therapeutic Advances in Neurological Disorders

Relations Between 6 Minute Walking Distance and 10 Meter Walking Speed in Patients With Multiple Sclerosis and Stroke

(2012) Ulrik Dalgas et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Validity and variability of the 5-repetition sit-to-stand test in patients with multiple sclerosis

(2012) Andreas Buch Møller et al.   DISABILITY AND REHABILITATION

Assessing walking disability in multiple sclerosis

(2012) Bernd C. Kieseier et al.   Multiple Sclerosis Journal

The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis

(2012) Tom Broekmans et al.   Multiple Sclerosis Journal

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis

(2011) Craig I. Coleman et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Danish Multiple Sclerosis Registry

(2011) Henrik Brønnum-Hansen et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

(2010) Andrew D. Goodman et al.   ANNALS OF NEUROLOGY

5-Repetition Sit-to-Stand Test in Subjects With Chronic Stroke: Reliability and Validity

(2010) Yiqin Mong et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

(2009) Andrew D Goodman et al.   LANCET

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable

(2008) C Heesen et al.   Multiple Sclerosis Journal